Puluo Pharmaceutical: Overseas CDMO project has passed official audit and has been put into commercial production.

According to information from Pulo Pharmaceuticals, recently, Pulo Pharmaceuticals and a long-term strategic partner from overseas have successfully advanced the innovative drug CDMO DS project together, and it has smoothly passed official audits overseas and entered the commercial production and supply stage.